HOME >> BIOLOGY >> NEWS
IBD (Crohn's, Colitis) 'joins' cancer, inflammatory diseases in associated blood vessel growth

Snowmass, Co. (September 13, 2004) Over at least the last decade it has been recognized that the growth of new blood vessels is critical in the pathogenesis of cancer because it increases blood supply to malignant tissue. Relatively recently, a novel pathogenic role of angiogenesis has been established for such chronic inflammatory diseases as rheumatoid arthritis, psoriasis and atherosclerosis.

As a result, suppressing neoangiogenesis is being investigated as a therapeutic approach for not only cancer, but also chronic inflammation.

Whether neoangiogenesis also occurs in Crohn's Disease (CD) and ulcerative colitis (UC), the major constituents of Inflammatory Bowel Diseases (IBD), has never been studied, according to the authors of a paper presented at an IBD translational conference sponsored by the American Physiological Society.

The paper is entitled, "Neoangiogenesis: a new component in Inflammatory Bowel Diseases pathogenesis."

Lead author Silvio Danese of Case Western Reserve University School of Medicine and Universita' Cattolica del S. Cuore, Rome, Italy, collaborated with colleagues Miquel Sans, Brenda Reyes-Rivera, Gail West, Homa Phillips, Joe Willis and Claudio Fiocchi at Case Western Reserve University School of Medicine; Carol de la Motte at the Cleveland Clinic Foundation; and Roberto Pola and Antonio Gasbarrini at Universita' Cattolica del S. Cuore.

According to Danese, "Our results show that increased vascularization is present in IBD, and the inflamed mucosal microenvironment actively promotes angiogenesis." Furthermore, he said that "the intestinal microvascularization of both CD and UC displays an activated profile as shown by the expression of angiogenic marker V3 integrin.

"Targeting this integrin could be a potential therapeutic approach for IBD," similar to approaches in other forms of chronic inflammation, Danese said. "These r
'"/>


13-Sep-2004


Page: 1 2 3

Related biology news :

1. Beware cancer, insomnia and liver disease UH students are taking aim
2. Purdue scientists: To stop cancer, keep your Icmt away from your Ras
3. Drug developed for rare disease may help millions more as treatment for cancer, autoimmune diseases
4. Telltale prostate cancer protein key to breast cancer, too
5. UGA receives $6.7 M grant that will add knowledge in fights against cancer, Parkinsons disease
6. Isolation of ferret protein promising for cancer, reproductive studies
7. UNC studies target molecular defects implicated in cancer, genetic diseases
8. Common human virus may be associated with colon cancer, according to Temple researchers
9. New technique widens the lens on cancer, could lead to new therapies
10. While some immune cells aim to fight cancer, others hold them in check
11. Amplified genome area mapped; New gene is overexpressed in oral cancer, say Pittsburgh researchers

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/4/2019)... N.J. (PRWEB) , ... August 02, 2019 , ... ... to assist the life science industry in advancing the development of medical therapies, ... been recognized by PharmaVOICE magazine as one of the “100 Most Inspiring People ...
(Date:8/1/2019)... SAN JOSE, Calif. (PRWEB) , ... July 31, ... ... and cell biology technologies, today announced the launch of the next generation of ... builds on the success of the industry-leading FLIPR® platform for monitoring of G-protein-coupled ...
(Date:7/26/2019)... ANGELES (PRWEB) , ... July 25, 2019 , ... ... platform, today announced the first mixed reality headsets to include a new generation ... SIGGRAPH 2019 Exhibition in Los Angeles, California (July 30 - August 1). ...
Breaking Biology News(10 mins):
(Date:8/6/2019)... ... August 05, 2019 , ... ... been recognized as a distinguished leader by PharmaVOICE magazine, earning him a prestigious ... in the magazine’s July/August special issue. , As the executive vice president of ...
(Date:7/23/2019)... , ... July 22, 2019 , ... ... companies with best-in-class services in the fields of 3D tissue imaging , ... learning , Visikol initially started back in 2013 as a products company. These ...
(Date:7/17/2019)... ... July 16, 2019 , ... Quidel is ... from Kalorama Information. Abbott, Roche and Siemens Healthineers and Response Biomedical also are ... Worldwide Market for Point-of-Care (POC) Diagnostics . , Quidel is a market ...
(Date:6/26/2019)... ... June 26, 2019 , ... Alice Branton today released research results from ... of Magnesium Gluconate, which can prove to be beneficial for treating Hypomagnesemia. , The ... peak, change in crystallite size , Over 142% increase in particle size ...
Breaking Biology Technology:
Cached News: